OSP FO# 11-208

AGENCY: Department of Health and Human Services (DHHS)/National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA)

PROGRAM: NIDA Program Project Grant Applications (P01)

OBJECTIVES: This program provides funding for investigator-initiated Program Project Grant (P01) applications from institutions/organizations to address critical issues of neuroscience, behavior, prevention, treatment, epidemiology, etiology, health services, HIV/AIDS or other drug abuse-related research areas.

There must be a unifying and well defined goal or problem area of research which clearly establishes the direction, objectives, and aims of the program project. In addition, there must be a minimum of three inter-related research projects that relate to and contribute toward those objectives and aims. Each research project must be supportable on its own merit, recognizing that the scientific merit of each research project is assessed independently, as well as within the context of the whole program.

The program project must utilize coordinated collaborative efforts in addressing the goal or problem area, and multidisciplinary perspectives are encouraged. The combination of specific projects should produce a context that allows each research effort to share the creative strengths of the others. Inter-relationships between component projects are expected to result in a greater contribution to the program goals than if each project were pursued separately. This enhanced productivity, or “synergy,” should be facilitated by the administrative and physical organization of the program, the composition of the research team, the selection of topics for study, coordinated scheduling of staff and support services, economies achieved through consolidated management, and in other ways as appropriate to the particular program project. While projects should cooperate and share resources to enhance productivity, individual projects should be able to exist independently.

ELIGIBILITY RESTRICTIONS: The program project must be led by a Project Director/Principal Investigator (PD/PI) who possesses recognized scientific and administrative competence. The PI must show a substantial commitment of time and effort to the program, at least 25% (3 calendar months) more than one PD/PI (i.e., multiple PDs/PIs) may be designated on the application. If the multi-PD/PI option is selected, each PD/PI must commit at least 20% (2.4 calendar months) time and effort. Effort may be divided between administrative and scientific duties.

DEADLINES:
Full Proposal: September 25, January 25, and May 25 annually until September 8, 2013

FUNDING INFORMATION: Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.

AGENCY CONTACT:
Jag Khalsa, Ph.D.
Chief, Medical Consequences of Drug Abuse and Co-occurring Infections Branch
Division of Pharmacotherapies and Medical Consequences of Drug Abuse
National Institute on Drug Abuse, NIH, DHHS
6001 Executive Boulevard, Room 4137, MSC 9551
Bethesda, Maryland 20892-9551
Telephone: (301) 443-2159
Fax: (301) 443-2599
Email: jkhalsa@nida.nih.gov
Web: http://grants.nih.gov/grants/guide/pa-files/PAR-10-244.html

REMARKS: Complete program guidelines and application material (PAR-10-244 and PHS 398) may be obtained from the web site listed above or from the Office of Sponsored Programs (OSP). Please distribute this notice to any faculty or staff members who might be interested in the information. For more information, please contact the OSP at X3-4365 or ospinfo@bu.edu, or visit the OSP web site at http://www.bu.edu/osp.